2. Signaling Pathways
  3. GPCR/G Protein
    Neuronal Signaling
  4. Dopamine Receptor
  5. Dopamine Receptor Control

Dopamine Receptor Control

Dopamine Receptor Isoform Comparison

Dopamine Receptor Controls (7):

Cat. No. Product Name Effect Purity
  • HY-141495A
    Razpipadon
    		Control 99.95%
    Razpipadon ((-)-PW0464) is an isomer of (Rac)-Razpipadon (HY-141495).
  • HY-116548
    Nitracaine
    		Control 98.95%
    Nitracaine is a structural analog of Dimethocaine (HY-121870), a local anesthetic that inhibits dopamine reuptake through the dopamine transporter.
  • HY-164703
    Lumateperone metabolite 1
    		Control 98.26%
    Lumateperone metabolite 1 (Formula T) is a metabolite of Lumateperone (HY-17637). Lumateperone (ITI-007) is an orally active 5-HT2A receptor antagonist (Ki = 0.54 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki = 32 nM), and a dopamine D1 receptor modulator
  • HY-114549
    (R)-SCH-23982 hydrochloride
    		Control
    (R)-SCH-23982 hydrochloride is the R-enantiomer of SCH-23982 hydrochloride. SCH-23982 hydrochloride is a selective dopamine D1 receptor antagonist. (R)-SCH-23982 hydrochloride is promising for research of central nervous system disorders such as schizophrenia, Parkinson’s disease.
  • HY-133728
    Piribedil N-oxide
    		Control
    Piribedil N-oxide is a metabolite of the dopamine receptor agonist Piribedil (HY-12707).
  • HY-Z2493
    Aripiprazole N1-oxide
    		Control
    Aripiprazole N-oxide is a metabolite of the atypical antipsychotic Aripiprazole (HY-14546). Aripiprazole N-oxide is formed from aripiprazole by the cytochrome P450 (CYP) isoforms CYP2D6 and CYP3A4.
  • HY-Z4466
    Olanzapine ketolactam
    		Control
    Olanzapine ketolactam (compound 1) is the impurity of Olanzapine (HY-14541). Olanzapine is a selective, orally active monoaminergic antagonist.